spondyloarthritis

Novartis takes aim at Eli Lilly with Cosentyx FDA nod in spondyloarthritis
Fierce Pharma
Wed, 06/17/20 - 09:57 am
Novartis
Eli Lilly
Cosentyx
Taltz
spondyloarthritis
FDA advisory panel votes against new use of AbbVie's Humira
Reuters
Wed, 07/24/13 - 09:51 am
FDA
advisory panels
AbbVie
Humira
spondyloarthritis
New Data on UCB's Cimzia
Yahoo/Zacks
Sat, 06/15/13 - 01:11 pm
UCB Pharmaceuticals
Cimzia
psoriatic arthritis
spondyloarthritis